Literature DB >> 33391186

Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.

Yiming Zhao1, Weiwei Liang1, Feng Cai2, Qun Wu2, Yongjian Wang1.   

Abstract

Background: Cushing's disease is associated with an increased risk of pulmonary fungal infection, which could be a relative contraindication for pituitary adenoma excision surgery. Case: We report a case of a patient with Cushing's disease and pulmonary Cryptococcus neoformans. A 48-year-old woman was admitted to our hospital because of moon face and edema. Laboratory and radiological findings suggested a diagnosis of Cushing's disease and pulmonary cryptococcus infection. Fluconazole 400 mg per day was administered intravenously and continued orally for 3 months. Both cryptococcus infection and hypercortisolism relieved and transsphenoidal resection was performed.
Conclusion: Cushing's disease can be effectively treated with fluconazole to normalize cortisol concentration prior to pituitary surgery. Fluconazole is an alternative treatment especially in Cushing's disease patients with cryptococcal pneumonia.
Copyright © 2020 Zhao, Liang, Cai, Wu and Wang.

Entities:  

Keywords:  Cushing’s disease; Cushing’s syndrome; fluconazole; hypercortisolism; medical treatment

Mesh:

Substances:

Year:  2020        PMID: 33391186      PMCID: PMC7774647          DOI: 10.3389/fendo.2020.608886

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  31 in total

1.  Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide.

Authors:  S Shibata; M Kami; Y Kanda; U Machida; H Iwata; Y Kishi; A Takeshita; S Miyakoshi; J Ueyama; S Morinaga; Y Mutou
Journal:  Am J Hematol       Date:  2001-04       Impact factor: 10.047

Review 2.  Targeting the BDNF/TrkB pathway for the treatment of tumors.

Authors:  Lingbin Meng; Baoqiong Liu; Rui Ji; Xin Jiang; Xuebo Yan; Ying Xin
Journal:  Oncol Lett       Date:  2018-12-20       Impact factor: 2.967

3.  Reversible acute adrenal insufficiency caused by fluconazole in a critically ill patient.

Authors:  S G Santhana Krishnan; R K Cobbs
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

Review 4.  Advances in the medical treatment of Cushing's syndrome.

Authors:  Richard A Feelders; John Newell-Price; Rosario Pivonello; Lynnette K Nieman; Leo J Hofland; Andre Lacroix
Journal:  Lancet Diabetes Endocrinol       Date:  2018-07-20       Impact factor: 32.069

5.  Fluconazole inhibits human adrenocortical steroidogenesis in vitro.

Authors:  R van der Pas; L J Hofland; J Hofland; A E Taylor; W Arlt; J Steenbergen; P M van Koetsveld; W W de Herder; F H de Jong; R A Feelders
Journal:  J Endocrinol       Date:  2012-10-04       Impact factor: 4.286

6.  Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.

Authors:  Maria Fleseriu; Rosario Pivonello; Atanaska Elenkova; Roberto Salvatori; Richard J Auchus; Richard A Feelders; Eliza B Geer; Yona Greenman; Przemyslaw Witek; Fredric Cohen; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2019-09-18       Impact factor: 32.069

7.  Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.

Authors:  D Dworakowska; E Wlodek; C A Leontiou; S Igreja; M Cakir; M Teng; N Prodromou; M I Góth; S Grozinsky-Glasberg; M Gueorguiev; B Kola; M Korbonits; A B Grossman
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678

8.  Primary adrenal insufficiency in patients with acquired immunodeficiency syndrome: report of four cases.

Authors:  Yi-Wen Huang; Ching-Chung Chang; Hsin-Yun Sun; Mao-Yuan Chen; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Microbiol Immunol Infect       Date:  2004-08       Impact factor: 4.399

9.  Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis.

Authors:  Verena Schwetz; Felix Aberer; Claudia Stiegler; Thomas R Pieber; Barbara Obermayer-Pietsch; Stefan Pilz
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-05-21

10.  STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data.

Authors:  Damian Szklarczyk; Alberto Santos; Christian von Mering; Lars Juhl Jensen; Peer Bork; Michael Kuhn
Journal:  Nucleic Acids Res       Date:  2015-11-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.